Drug reference
Iontophoretic treatment of hyperhidrosis ▶TO THE SKIN ▶Adult: Only 1 site to be treated at a time, maximum 2 sites treated in any 24 hours, treatment not to be repeated within 7 days (consult product literature)
PDF page 1353
Infections affecting the treatment site CONTRA-INDICATIONS, FURTHER INFORMATION Contra- indications applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.
PDF page 1353
Cautions applicable to systemic use should be considered; however, glycopyrronium is poorly absorbed and systemic effects unlikely with topical use.
PDF page 1353
→Appendix 1: glycopyrronium
PDF page 1353
Abdominal discomfort. eating disorder. pain. paraesthesia SIDE-EFFECTS, FURTHER INFORMATION The possibility of systemic side-effects should be considered; however, glycopyrronium is poorly absorbed and systemic effects are unlikely with topical use.
PDF pages 1353, 1354
There can be variation in the licensing of different medicines containing the same drug. Powder for solution for iontophoresis ▶Glycopyrronium bromide (Non-proprietary) Glycopyrronium bromide 1 mg per 1 mg Glycopyrronium bromide powder for solution for iontophoresis | 3 gram P £327.00 DT = £327.00 DERMATOLOGICAL DRUGS › ASTRINGENTS
PDF page 1354
Only 1 site to be treated at a time, maximum 2
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1353
